Document is current

Any future updates will be listed below

Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects

Crossref DOI link: https://doi.org/10.1007/s00520-015-2783-9

Published Online: 2015-06-04

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark